Zymeworks Inc. officer Scott Platshon filed a Form 144 notice of proposed sale on November 18, 2026, disclosing plans to sell 15,292 shares of common stock through Morgan Stanley Wealth Management Canada.
Key Highlights
- Proposed sale size: 15,292 shares of Zymeworks Inc. common stock, with an aggregate market value of $395,145.28, according to the filing.
- Source of shares: The filing states the shares were acquired on November 18, 2026, through the vesting of Restricted Stock Units granted by the issuer.
- Approximate sale date: The filing lists November 18, 2026, as the approximate date of sale.
- Shares outstanding: The filing reports 69,030,691 shares of common stock outstanding at the time of filing.
- Broker named: Morgan Stanley Wealth Management Canada, located at 140 4th Ave. SW, Suite 2740, Calgary, is identified as the broker for the proposed sale.
- Prior sales: The filing reports nothing to disclose under securities sold during the past three months.
Zymeworks Officer Discloses RSU Vesting and Proposed Share Sale
According to the Form 144 filed with the U.S. Securities and Exchange Commission, Scott Platshon, identified as an officer of Zymeworks Inc. (NASDAQ:ZYME), provided notice of a proposed sale of 15,292 shares of the company's common stock. The filing lists an aggregate market value of $395,145.28 for the shares proposed to be sold. The notice was dated November 18, 2026.
The filing discloses that the shares to be sold were acquired on November 18, 2026, through the vesting of Restricted Stock Units, with the issuer, Zymeworks Inc., named as the person from whom the securities were acquired. The nature of payment is listed as "Vesting of Award." The proposed sale is to be executed through Morgan Stanley Wealth Management Canada, based in Calgary.
The filing states that Platshon reported no sales of Zymeworks securities in the three months preceding the notice. By signing the Form 144, Platshon represented, as stated in the filing, that he "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed." Zymeworks Inc. is listed on Nasdaq and is incorporated in Delaware, with its registered address at 108 Patriot Drive, Suite A, Middletown, Delaware 19709.
What Was Disclosed
Zymeworks officer Scott Platshon filed a Form 144 on November 18, 2026, proposing to sell 15,292 common shares valued at $395,145.28 in aggregate, acquired through RSU vesting on the same date, with no prior sales in the preceding three months reported.




Please wait processing your request...